Pembrolizumab and Stereotactic Radiotherapy Combined in Subjects with Advanced HCC: A Phase II Study (PEMRAD).
Journal of Clinical Oncology(2025)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined